Courage Therapeutics Completes Seed Financing to Advance Its Melanocortin Obesity and Diseases of Wasting Drug Programs
ANN ARBOR, Mich.–(BUSINESS WIRE)–Courage Therapeutics, a company developing novel treatments for genetic and dietary obesity and diseases of wasting, today announced it has closed funding led by Arsenal Bridge Ventures, a venture capital firm specializing…